Through these means, we sought to examine the effect of stiffness on RASSF1A expression in the context of MD and in BRCA WT versus mutant backgrounds in order to better understand the combinatory contribution of high MD and BRCA1/2 gene mutations to breast cancer risk. The gene discussed is RASSF1; the disease is breast carcinoma.